Drug recall · August 24, 2022
Ketorolac Tromethamine Injection recall
Why: cGMP Deviations: deviations leading to potential cross-contamination.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron Pharmaceutical Corporation 4500 12th Street Extension West Columbia, SV 29172, NDC 0487-6232-01
- Lots / codes
Lot#: 023011 Exp 8/31/2022
- Quantity
- 5040 vials
- Company
- Nephron Sc Inc, West Columbia, SC
- Distribution
- USA Nationwide
- Initiated
- August 10, 2022 · Voluntary: Firm initiated
- Classified
- August 17, 2022
- Reported
- August 24, 2022
- Ended
- September 24, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ketorolac
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.